Suraksha Diagnostic is currently trading at RS. 324.90, up by 0.90 points or 0.28% from its previous close of RS. 324.00 on the BSE.

The stock opened at RS. 325.00 and moved between a high of RS. 325.60 and a low of RS. 320.65 during the session. A total of 1548 shares have been traded so far.

Classified under BSE group 'B', the stock with a face value of RS. 2 has touched a 52-week high of RS. 449.00 on December 6, 2024, and a 52-week low of RS. 233.15 on March 4, 2025. In the last week, the scrip has fluctuated between RS. 331.40 and RS. 317.85. The company currently has a market capitalization of RS. 1690.02 crore.

The promoter holding in the company stands at 48.78%, while institutions and non-institutions hold 36.51% and 14.70%, respectively.

Suraksha Diagnostic has announced plans to invest RS. 200 crore to establish over 20 advanced imaging centres across eastern India. This initiative, in collaboration with United Imaging, aims to boost access to affordable and high-quality diagnostic services in tier 2 and tier 3 cities, particularly in semi-urban and smaller towns.

Under the partnership, United Imaging will provide state-of-the-art imaging equipment, while Suraksha will utilize its extensive network and expertise to roll out the new centres. The company had raised RS. 846.25 crore through its IPO in December to support this expansion.

Currently, Suraksha Diagnostic operates 59 diagnostic centres and 166 sample collection centres across West Bengal, Bihar, Assam, and Meghalaya. The company specializes in providing a range of pathological and radiological services.